Načítá se...

Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study

BACKGROUND: Extended dosing of the erythropoiesis-stimulating agent (ESA) darbepoetin alfa (DA) once biweekly or monthly reduces anaemia treatment burden. This observational study assessed outcomes and dosing patterns in patients with chronic kidney disease not on dialysis (CKD-NoD) commencing exten...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nephrol Dial Transplant
Hlavní autoři: Galle, Jan-Christoph, Addison, Janet, Suranyi, Michael G., Claes, Kathleen, Di Giulio, Salvatore, Guerin, Alain, Herlitz, Hans, Kiss, István, Farouk, Mourad, Manamley, Nick, Wirnsberger, Gerhard, Winearls, Christopher
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5146706/
https://ncbi.nlm.nih.gov/pubmed/27190334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfw047
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!